Polyion complex micelles composed of all-trans retinoic acid and poly (ethylene glycol)-grafted-citosan

被引:63
作者
Jeong, Young-Il
Kim, Sang-Hyo
Jung, Tae-Young
Kim, In-Young
Kang, Sam-Suk
Jin, Yong-Hao
Ryu, Hyang-Hwa
Sun, Heung-Suk
Jin, Shuguang
Kim, Kyung-Keun
Ahn, Kyu-Youn
Jung, Shin [1 ]
机构
[1] Chonnam Natl Univ, Sch Med, Brain Tumor Res Lab, Res Inst Med Sci, Kwangju 501746, South Korea
[2] Chonnam Natl Univ, Hwasun Hosp, Dept Neurosurg, Jeollanam Do 519809, South Korea
关键词
PEG-grafted chitosan; all-trans retinoic acid; ion complex; polymeric micelle; brain tumor cell;
D O I
10.1002/jps.20586
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The goal of this study is to develop novel types of polyion complex micelles for the drug delivery to brain tumor. Methoxy poly(ethylene glycol) (mPEG)-grafted chitosan (CP) was synthesized in order to make polymeric micelles encapsulating all-trans retinoic acid (ATRA) based on polyion complex formation. Polyion complex micelles were found to have spherical shapes with sizes of about 50 similar to 200 nm. The loading efficiency of micelle was higher than 80% (w/w) for all formulations. H-1 nuclear magnetic resonance (NMR) spectra confirmed the formation of polymeric micelles. The CP graft copolymer and ATRA have distinguishing peaks in their H-1 NMR spectra. The specific peaks of ATRA disappeared in D2O or DMSO while it appeared at mixtures of D2O/ DMSO, indicating that ATRA and chitosan formed ion complex inner-core. In the cell cytotoxicity study using U87MG cells in vitro, polyion complex micelles showed similar cytotoxicity to that of free ATRA. A migration test was performed to investigate the inhibition of tumor cell invasion in vitro. The results suggested that the polyion complex micelles was more effective at inhibiting tumor cell migration than free ATRA. (c) 2006 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:2348 / 2360
页数:13
相关论文
共 34 条
[1]  
ACHKAR CC, 1994, DRUG METAB DISPOS, V22, P451
[2]   PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release [J].
Bhattarai, N ;
Ramay, HR ;
Gunn, J ;
Matsen, FA ;
Zhang, MQ .
JOURNAL OF CONTROLLED RELEASE, 2005, 103 (03) :609-624
[3]   Retinoids inhibit human glioma cell proliferation and migration in primary cell cultures but not in established cell lines [J].
Bouterfa, H ;
Picht, T ;
Kess, D ;
Herbold, C ;
Noll, E ;
Black, PM ;
Roosen, K ;
Tonn, JC .
NEUROSURGERY, 2000, 46 (02) :419-430
[4]   Long-term delivery of all-trans-retinoic acid using biodegradable PLLA/PEG-PLLA blended microspheres [J].
Choi, Y ;
Kim, SY ;
Kim, SH ;
Lee, KS ;
Kim, C ;
Byun, Y .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 215 (1-2) :67-81
[5]   Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics [J].
Conley, BA ;
Egorin, MJ ;
Sridhara, R ;
Finley, R ;
Hemady, R ;
Wu, SL ;
Tait, NS ;
VanEcho, DA .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 39 (04) :291-299
[6]   All-trans retinoic acid in relapsing malignant gliomas: Clinical and radiological stabilization associated with the appearance of intratumoral calcifications [J].
Defer, GL ;
AdleBiassette, H ;
Ricolfi, F ;
Martin, L ;
Authier, FJ ;
Chomienne, C ;
Degos, L ;
Degos, JD .
JOURNAL OF NEURO-ONCOLOGY, 1997, 34 (02) :169-177
[7]   Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia [J].
Estey, EH ;
Giles, FJ ;
Kantarjian, H ;
O'Brien, S ;
Cortes, J ;
Freireich, EJ ;
Lopez-Berestein, G ;
Keating, M .
BLOOD, 1999, 94 (07) :2230-2235
[8]   Gliadin nanoparticles for the controlled release of all-trans-retinoic acid [J].
Ezpeleta, I ;
Irache, JM ;
Stainmesse, S ;
Chabenat, C ;
Gueguen, J ;
Popineau, Y ;
Orecchioni, AM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 131 (02) :191-200
[9]   Enhancement of nasal absorption of insulin using chitosan nanoparticles [J].
Fernández-Urrusuno, R ;
Calvo, P ;
Remuñán-López, C ;
Vila-Jato, JL ;
Alonso, MJ .
PHARMACEUTICAL RESEARCH, 1999, 16 (10) :1576-1581
[10]   THE RETINOIC ACID SYNDROME IN ACUTE PROMYELOCYTIC LEUKEMIA [J].
FRANKEL, SR ;
EARDLEY, A ;
LAUWERS, G ;
WEISS, M ;
WARRELL, RP .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (04) :292-296